StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$157.72−4.84 (-2.98%)

Close on Nov 17, 2026Market cap $6.20BP/E –Yield –

Belite Bio revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Belite Bio

Belite Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Belite Bio figures

See a number that looks wrong?